Decreases in muscle size, muscle force, and TB mass in 3-mo Lmna^HSA-cko mice. by Lei Xiong (334812)

The <i>P[syt^P-L]</i> mutation decreases the Ca²⁺ affinity of release and vesicular release probability, but the readily releasable pool is unchanged. by Mallory C. Shields (4474210)

“…Application of bath solution does not result in an increase in mEJP frequency in either genotype (open circles) (p = 0.57 for <i>+/-; P[syt^WT]/+</i> and p = 0.83 for <i>+/-;P[syt^P-L]/+</i>, student t-test). Scale bar 2mV, 3s. (D) Paired-pulse analysis indicates a decrease in release probability in <i>+/-;P[syt^P-L]/+</i>. …”

Drugs which cluster on the 'anxiolytic' group decrease 5-HT turnover in the brain. by Caio Maximino (100467)

“…A negative correlation is found between the decrease in serotonin turnover and the increase in time on white produced by a drug (r² = 0.5688, p = 0.0073).…”

Algal oil and Meganol D decreased early vascular lesions and upregulate plasma SPM in APOE^-/- mice. by Agua Sobrino (368634)

Silencing <i>cullin-1/5</i> decreased mRNA and protein expression of NF-κB dependent cytokines. by Attinder Chadha (11414273)

Subjects:

Five compounds significantly decrease MAPK1 phosphorylation in K562 cells. by Pamela Y. Ting (713174)

Nimodipine does not decrease markers of neuritic dystrophy in 5XFAD transgenic mice. by Katherine R. Sadleir (12035242)

“…<p><b>(</b>A and F) Representative immunoblots of hippocampal (A) and cortical (F) lysates of non-transgenic and 5XFAD mice treated with vehicle or nimodipine. …”

Exercise testing criteria to diagnose lower extremity peripheral artery disease assessed by computed-tomography angiography by O. Stivalet (6890189)

“…In the subset of patients with an ABI >0.91, cut-off values of post-exercise ABI decrease (AUC = 0.67[0.53–0.78]), and DROP (AUC = 0.67[0.53–0.78]) were ≥18.5%, and ≤-15mmHg respectively (p<0.05).…”

Decrease of HLA-DR expression is more pronounced in severe cases. by Sanja Matic (9931091)

Nicotine decreased Akt phosphorylation in SK-BR-3 cells. by Masanori A. Murayama (5774585)

Dexamethasone decreases CRTC1 and CRTC2 nuclear localization. by Jill A. Rahnert (2872766)

“…<p>Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased (A) total CRTC1 (p = 0.004 and CRTC2 protein (p = 0.0007). n = 9/treatment from 3 experiments. …”

Dexamethasone decreases PGC-1α protein expression and transcription. by Jill A. Rahnert (2872766)

“…<p>(A) Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased PGC-1α protein expression (p = 0.01). n = 3/treatment from 3 experiments. …”

Treatment with con-G showed improved neurological scoring and decreased peri-infarct Ca²⁺ microdeposits. by Rashna Balsara (714796)

ABCC3 overexpression decreases the retention of anti-cancer agents. by Sai A. Balaji (1452556)

RNF5 depletion decreases cellular gene expression and lytic replication through increased EphA3 and EphA4 level in iSLK.219 cells. by Xiaojuan Li (351842)

Decreased proliferation after overexpression of T-STAR in five breast cancer cell lines. by Sandra Sernbo (438551)

“…B) Increased (676%) T-STAR protein level (WB) compared to GFP (16%) and wt (100%) control cells in the MDA-MB-231 cell line after overexpression. C) A decrease in proliferation could be detected at 48 h after overexpressing T-STAR using thymidine incorporation and D) after 48 h (PMC42, L56Br-C1 and T47D) or 72 h (JIMT-1 and MDA-MB-231) upon assessment of enzymatic activity (WST-1 assay). …”

Increasing temperature does not increase the sensitivity of hatching to pre-incubation with rotenone for 5 d under anoxia. by Joseph A. Covi (3131166)

PrP^C, but not CNTN5, is decreased in sporadic AD. by Isobel J. Whitehouse (331843)

Spleen PAX5 significantly decreased in APRIL/BLyS blockade treated mice. by Natalie M. Bath (6316517)

RL2 decreases viability and induces apoptosis in cultured cells. by Olga A. Koval (548122)